Concepedia

Liying Zhang

LZ

Statistics

Publications

14

Citations

925

H-Index

12

Active since

2008

Affiliations

Pfizer (United States)(Current)

University of North Carolina at Chapel Hill

Rutgers, The State University of New Jersey

Liying Zhang is an author at Pfizer (United States) specializing in drug discovery, pharmacology, and drug design.

ORCID

Publications per year

2008–2023

14

Publications

14

QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds

Liying Zhang, Hao Zhu, Tudor I. Oprea et al. · Pharmaceutical Research · 2008 · 201 citations

, , +16

Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( <i>S</i> )-2,2-Difluorocyclopropyl)((1 <i>R</i> ,5 <i>S</i> )-3-(2-((1-methyl-1 <i>H</i> -pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)

Andrew Fensome, Catherine M. Ambler, Eric P. Arnold et al. · Journal of Medicinal Chemistry · 2018 · 174 citations · Full text

, , +17

Discovery of Novel Antimalarial Compounds Enabled by QSAR-Based Virtual Screening

Liying Zhang, Denis Fourches, Alexander Sedykh et al. · Journal of Chemical Information and Modeling · 2012 · 96 citations

, , +17

Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches

Liying Zhang, Alexander Sedykh, Ashutosh Tripathi et al. · Toxicology and Applied Pharmacology · 2013 · 81 citations

, , +12

Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing

Jonathan L. Chen, Peiyuan Zhang, Masahito Abe et al. · Journal of the American Chemical Society · 2020 · 80 citations · Full text

, , +15

1–5 of 14